Current and historical daily PS Ratio for Hologic Inc (
) from 1990 to Jul 22 2026. The price to sales ratio is calculated by taking the current stock price and dividing it by the trailing twelve-month sales per share. The data is updated every 20 minutes during market hours. The PS ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS ratio is a great valuation tool for evaluating cyclical businesses where the PE ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean. Hologic stock (HOLX) PS ratio as of Jul 22 2026 is 4.16.
More Details
Hologic Inc (HOLX) PS Ratio Chart
Hologic Inc (HOLX) PS Ratio Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1136
- 1
- 2
- 3
- 4
- 5
- 6
- 13
| Hologic PS Ratio Historical Data | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date | PS Ratio Data | Date | PS Ratio Data | ||||||
| 2026-07-22 | 4.2 | 4.16 | 4.16 | 4.16 | 2026-02-02 | 4.1 | 4.1 | 4.09 | 4.09 |
| 2026-04-07 | 4.2 | 4.16 | 4.16 | 4.16 | 2026-01-30 | 4.1 | 4.11 | 4.09 | 4.1 |
| 2026-04-06 | 4.2 | 4.16 | 4.16 | 4.16 | 2026-01-29 | 4.1 | 4.11 | 4.1 | 4.1 |
| 2026-04-02 | 4.1 | 4.14 | 4.13 | 4.14 | 2026-01-28 | 4.1 | 4.11 | 4.11 | 4.11 |
| 2026-04-01 | 4.1 | 4.14 | 4.13 | 4.14 | 2026-01-27 | 4.1 | 4.12 | 4.1 | 4.11 |
| 2026-03-31 | 4.1 | 4.14 | 4.13 | 4.14 | 2026-01-26 | 4.1 | 4.12 | 4.11 | 4.11 |
| 2026-03-30 | 4.2 | 4.15 | 4.13 | 4.13 | 2026-01-23 | 4.1 | 4.11 | 4.1 | 4.11 |
| 2026-03-27 | 4.1 | 4.14 | 4.13 | 4.14 | 2026-01-22 | 4.1 | 4.12 | 4.11 | 4.11 |
| 2026-03-26 | 4.1 | 4.14 | 4.13 | 4.14 | 2026-01-21 | 4.1 | 4.12 | 4.1 | 4.11 |
| 2026-03-25 | 4.1 | 4.14 | 4.13 | 4.13 | 2026-01-20 | 4.1 | 4.11 | 4.1 | 4.11 |
| 2026-03-24 | 4.1 | 4.14 | 4.13 | 4.13 | 2026-01-16 | 4.1 | 4.11 | 4.1 | 4.1 |
| 2026-03-23 | 4.1 | 4.14 | 4.12 | 4.14 | 2026-01-15 | 4.1 | 4.11 | 4.1 | 4.1 |
| 2026-03-20 | 4.1 | 4.13 | 4.12 | 4.13 | 2026-01-14 | 4.1 | 4.11 | 4.1 | 4.11 |
| 2026-03-19 | 4.1 | 4.13 | 4.11 | 4.12 | 2026-01-13 | 4.1 | 4.1 | 4.09 | 4.1 |
| 2026-03-18 | 4.1 | 4.11 | 4.1 | 4.11 | 2026-01-12 | 4.1 | 4.1 | 4.09 | 4.1 |
| 2026-03-17 | 4.1 | 4.12 | 4.11 | 4.11 | 2026-01-09 | 4.1 | 4.1 | 4.09 | 4.1 |
| 2026-03-16 | 4.1 | 4.11 | 4.1 | 4.11 | 2026-01-08 | 4.1 | 4.11 | 4.09 | 4.1 |
| 2026-03-13 | 4.1 | 4.12 | 4.11 | 4.11 | 2026-01-07 | 4.1 | 4.1 | 4.09 | 4.1 |
| 2026-03-12 | 4.1 | 4.13 | 4.11 | 4.11 | 2026-01-06 | 4.1 | 4.11 | 4.09 | 4.1 |
| 2026-03-11 | 4.1 | 4.13 | 4.12 | 4.13 | 2026-01-05 | 4.1 | 4.1 | 4.08 | 4.09 |
| 2026-03-10 | 4.1 | 4.13 | 4.12 | 4.13 | 2026-01-02 | 4.1 | 4.08 | 4.07 | 4.08 |
| 2026-03-09 | 4.1 | 4.14 | 4.13 | 4.14 | 2025-12-31 | 4.1 | 4.08 | 4.07 | 4.07 |
| 2026-03-06 | 4.1 | 4.14 | 4.13 | 4.14 | 2025-12-30 | 4.1 | 4.08 | 4.07 | 4.08 |
| 2026-03-05 | 4.1 | 4.14 | 4.12 | 4.14 | 2025-12-29 | 4.1 | 4.08 | 4.07 | 4.08 |
| 2026-03-04 | 4.1 | 4.14 | 4.12 | 4.14 | 2025-12-26 | 4.1 | 4.13 | 4.12 | 4.13 |
| 2026-03-03 | 4.1 | 4.13 | 4.12 | 4.13 | 2025-12-24 | 4.1 | 4.14 | 4.11 | 4.13 |
| 2026-03-02 | 4.1 | 4.13 | 4.11 | 4.13 | 2025-12-23 | 4.2 | 4.16 | 4.15 | 4.15 |
| 2026-02-27 | 4.1 | 4.13 | 4.12 | 4.12 | 2025-12-22 | 4.2 | 4.16 | 4.15 | 4.15 |
| 2026-02-26 | 4.1 | 4.12 | 4.11 | 4.12 | 2025-12-19 | 4.2 | 4.16 | 4.15 | 4.15 |
| 2026-02-25 | 4.1 | 4.12 | 4.12 | 4.12 | 2025-12-18 | 4.2 | 4.16 | 4.15 | 4.15 |
| 2026-02-24 | 4.1 | 4.13 | 4.12 | 4.12 | 2025-12-17 | 4.2 | 4.17 | 4.15 | 4.15 |
| 2026-02-23 | 4.1 | 4.13 | 4.12 | 4.13 | 2025-12-16 | 4.2 | 4.17 | 4.16 | 4.16 |
| 2026-02-20 | 4.1 | 4.13 | 4.11 | 4.13 | 2025-12-15 | 4.2 | 4.18 | 4.16 | 4.17 |
| 2026-02-19 | 4.1 | 4.12 | 4.1 | 4.11 | 2025-12-12 | 4.2 | 4.16 | 4.15 | 4.16 |
| 2026-02-18 | 4.1 | 4.12 | 4.11 | 4.11 | 2025-12-11 | 4.2 | 4.15 | 4.14 | 4.15 |
| 2026-02-17 | 4.1 | 4.12 | 4.11 | 4.11 | 2025-12-10 | 4.2 | 4.16 | 4.15 | 4.15 |
| 2026-02-13 | 4.1 | 4.11 | 4.1 | 4.11 | 2025-12-09 | 4.2 | 4.16 | 4.15 | 4.15 |
| 2026-02-12 | 4.1 | 4.11 | 4.1 | 4.1 | 2025-12-08 | 4.2 | 4.16 | 4.14 | 4.15 |
| 2026-02-11 | 4.1 | 4.12 | 4.11 | 4.11 | 2025-12-05 | 4.2 | 4.16 | 4.15 | 4.16 |
| 2026-02-10 | 4.1 | 4.12 | 4.11 | 4.11 | 2025-12-04 | 4.2 | 4.16 | 4.13 | 4.15 |
| 2026-02-09 | 4.1 | 4.1 | 4.09 | 4.1 | 2025-12-03 | 4.2 | 4.16 | 4.15 | 4.16 |
| 2026-02-06 | 4.1 | 4.1 | 4.09 | 4.09 | 2025-12-02 | 4.2 | 4.16 | 4.15 | 4.15 |
| 2026-02-05 | 4.1 | 4.1 | 4.08 | 4.09 | 2025-12-01 | 4.2 | 4.16 | 4.14 | 4.15 |
| 2026-02-04 | 4.1 | 4.09 | 4.08 | 4.08 | 2025-11-28 | 4.1 | 4.16 | 4.14 | 4.16 |
| 2026-02-03 | 4.1 | 4.1 | 4.08 | 4.08 | 2025-11-26 | 4.1 | 4.15 | 4.14 | 4.15 |
Hologic Inc (HOLX) PS Ratio Comparison
| Company | Market Cap(Mil) | PS Ratio |
|---|
Business Description
Business Description
Hologic Inc
NAICS : 334517
SIC : 3844
ISIN : US4364401012
Share Class Description:
HOLX: Ordinary SharesTotal Employee Number:
7,070Compare
Compare
Traded in other countries / regions
HOLX.USAHOLX.AustriaH1OL34.BrazilHO1.Germany0J5Q.UK1HOLX.ItalyHOLX.Mexico Index Membership
Russell 1000Russell 3000MSCI World IndexNASDAQ 100NASDAQ 100S&P 500 IPO Date
1990-03-01Description
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.